COR
Cencora, Inc. · Healthcare · Medical - Distribution
Momentum inputs (comparable managers):
holder breadth +5.9% ·
share flow +8.4% ·
net new positions +5.6%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 466.89K | $143.79M | n/a | −2 |
| Q2 2026 | 161 | 0 | 138.36M | $39.16B | +5 | −6 |
| Q1 2026 | 165 | -4 | 143.75M | $45.15B | +4 | −9 |
| Q4 2025 | 168 | -1 | 154.98M | $52.35B | +1 | −1 |
| Q3 2025 | 24 | +1 | 95.47M | $29.83B | +1 | −1 |
| Q2 2025 | 21 | 0 | 79.61M | $23.87B | n/a | n/a |
| Q1 2025 | 18 | +1 | 37.02M | $10.29B | +2 | −1 |
| Q4 2024 | 17 | 0 | 34.14M | $7.67B | n/a | n/a |
| Q3 2024 | 16 | 0 | 25.36M | $5.70B | n/a | n/a |
| Q2 2024 | 16 | n/a | 24.85M | $5.60B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 9.65M | +8.9% | $2.68B | 0.3% | ▲ Add | 4 | SEC ↗ ×2 |
| 2 | State Street Global Advisors ✦ (passive) | 8.41M | +4.8% | $2.34B | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 5.42M | +7.2% | $1.51B | 0.3% | ▲ Add | 4 | SEC ↗ ×9 |
| 4 | Geode Capital Management ✦ (passive) | 4.50M | +4.1% | $1.25B | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passive) | 2.37M | +11.3% | $658.67M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 1.43M | -2.6% | $396.55M | 0.4% | ▼ Trim | 4 | SEC ↗ ×5 |
| 7 | Viking Global Investors ✦ | 1.07M | New | $296.95M | 0.9% | New | 1 | SEC ↗ |
| 8 | Arrowstreet Capital ✦ | 886.62K | -12.9% | $246.56M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 858.61K | +14.5% | $238.77M | 0.5% | ▲ Add | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 710.47K | -19.7% | $197.57M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 605.97K | +454.8% | $168.52M | 0.2% | ▲ Add | 4 | SEC ↗ ×2 |
| 12 | Point72 Asset Management ✦ | 435.73K | New | $121.17M | 0.4% | New | 1 | SEC ↗ |
| 13 | Marshall Wace ✦ | 258.51K | -16.9% | $71.89M | 0.1% | ▼ Trim | 4 | SEC ↗ ×3 |
| 14 | D. E. Shaw & Co. ✦ | 198.66K | -4.2% | $55.25M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 15 | Adage Capital Partners ✦ | 161.26K | -12.0% | $44.85M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 36.27K | -38.1% | $10.09M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 13.67K | -93.1% | $3.80M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 1.22K | +11.9% | $339,753 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Viking Global Investors | $296.95M | 0.9% |
| Point72 Asset Management | $121.17M | 0.4% |
Exited
| Renaissance Technologies | $123.73M | was 0.2% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,407 holders, 152.27M shares, $41.91B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 986 sh · $298,935
Director · 1.28K sh · $411,264
Officer · 985 sh · $321,080
Officer · 11.30K sh · $3.66M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology